Selecting here opens the current stored cards. The pinned link below records their fingerprints. Do not enter patient information in links or searches.
Share or print this source review
1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.
Copy is optional; the link can be selected and copied manually. No patient data or dose decision is collected.
Clinical context remains essential
Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.
Check source scope before reading a dose
Linezolid - UCSF qualified renal guidance
Product / population
Linezolid - UCSF qualified renal guidance; selected renal source sections only, not a complete prescribing monograph.
Renal method
Creatinine clearance (CrCl), mL/min; selected passage does not establish an estimating equation.
Source revision
Source revision date not established in selected retrieval.
Retrieved
2026-09-08
Local review status
Selected source text imported locally; independent clinical review pending. Not a complete prescribing monograph.
Documented differences and cautions on this drug
All record notes are retained here, including notes about sources not selected in this review.
Label guidance versus selected expert dose reduction
The label does not require routine renal reduction. UCSF describes a selected strategy for stable patients with CrCl below 30 and an anticipated course longer than 10 days, after the initial 72 hours.
What to reconcile: Do not apply a reduced regimen universally. Retain the clinical-stability, duration, monitoring and specialist qualifiers.
Source difference identified; final patient-specific adjudication required.
Linezolid: qualified expert reduction versus label no-adjustment
UCSF describes an optional expert reduction for selected stable patients receiving a prolonged course, rather than a universal renal reduction. Its dialysis table remains separately stated.
What to reconcile: Document the source and qualifying clinical context; involve infectious diseases and consider drug-level monitoring. Do not apply the expert exception indiscriminately.
University of California San Francisco, Infectious Diseases Management Program · Linezolid - UCSF qualified renal guidance; selected renal source sections only, not a complete prescribing monograph.
Renal method: Creatinine clearance (CrCl), mL/min; selected passage does not establish an estimating equation. Source date: Source revision date not established in selected retrieval. Retrieved: 2026-09-08
Dose or interval guidance. Use only the product, indication, renal metric and population described in this source.
Selected source text imported locally; independent clinical review pending. Not a complete prescribing monograph.
Renal dosing, restrictions and evidence limits
UCSF generally lists 600 mg IV or orally every 12 hours without renal adjustment. For clinically stable patients with CrCl <30 mL/min and an anticipated course longer than 10 days, some experts consider 300 mg every 12 hours after the first 72 hours to reduce thrombocytopenia risk; therapeutic drug monitoring and ID/pharmacy consultation may assist. Its hemodialysis table retains 600 mg every 12 hours. This qualified expert option is not a universal renal reduction or a replacement for indication-specific regimens.
This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.
GlobalRPh v6.6 | RDM66-DIRECT-PHP-20260911 | Local library date 2026-09-11. Selected-card identity does not imply clinical verification.